Mirum Pharmaceuticals, Inc. (MIRM) — Dilution Risk Analysis

Current Snapshot

Mirum Pharmaceuticals, Inc. (MIRM) has a DilutionWatch score of 23/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
64,932,203 Source
Public Float
52,480,444 Source
Float as % of Outstanding
80.8%

Dilution Risk Score

Score: 23/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: SC 13G/A 1, 4 6, SC 13G 1, XBRL 1, 8-K/A 1.

FormFiledAccession
SC 13G/A 2026-08-13 0001274173-26-000210
4 2026-08-12 0001197350-26-000009
SC 13G 2026-08-06 0000315066-26-002080
xbrl 2026-06-30 xbrl-1985-xbrl_convertible
4 2026-04-16 0001547959-26-000007
8-K/A 2026-04-08 0001759425-26-000021
4 2026-03-17 0001614740-26-000009
4 2026-03-17 0001974200-26-000008
4 2026-03-17 0001650131-26-000010
4 2026-03-17 0001547959-26-000006

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 21 months Source
Three-year share count growth 39.3% Source

DilutionWatch Analysis

Risk Level
LOW (Score: 23/10) Source
Cash Runway
21 months Source
Share Count Growth (3-Year)
39.3% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.